Opportunity Information: Apply for CDC RFA GH13 130104CONT16
Apply for CDC RFA GH13 130104CONT16
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Poliomyelitis Eradication Initiative and Expanded Programme On Immunization" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185 Immunization Research, Demonstration, Public Information and EducationTraining and Clinical Skills Improvement Projects.
- This funding opportunity was created on Aug 1, 2015 and posted on Aug 1, 2015.
- Applicants must submit their applications by Sep 25, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under GH13 1301 Poliomyelitis Eradication Initiative and Expanded Programme On Immunization
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The funding opportunity titled "Poliomyelitis Eradication Initiative and Expanded Programme On Immunization" (Funding Opportunity Number: CDC RFA GH13-130104CONT16) is a continuation cooperative agreement administered by the Centers for Disease Control and Prevention (CDC) under the broad activity area of health. It is tied to CFDA 93.185, which covers immunization-related research, demonstration, public information and education, training, and clinical skills improvement projects. The announcement was posted and created on August 1, 2015, with an application closing date of September 25, 2015, and an archive date of October 25, 2015. The opportunity indicates an expected 50 awards, reflecting an ongoing, multi-award effort rather than a single grant.
This particular notice is not an open competition. It is explicitly described as continuation funding and is intended only for recipients that were already funded under the earlier related program announcement "GH13-1301 Poliomyelitis Eradication Initiative and Expanded Programme On Immunization." In practical terms, that means eligibility is restricted to existing grantees that previously received awards under the original program, and new applicants that were not part of the prior award cohort would not be able to compete for these funds. The eligible applicant category is listed as "Others," but the eligibility clarification makes clear that "others" refers to those prior grantees, not the general public.
The funding instrument is a cooperative agreement, which matters because it generally implies substantial involvement by the CDC in the work supported by the award. Compared with a standard grant, a cooperative agreement commonly includes closer technical collaboration, federal participation in planning or oversight, and more active engagement in program implementation and monitoring, especially in large public health initiatives like polio eradication and immunization system strengthening.
The opportunity does not require cost sharing or matching, so recipients are not required to contribute a specified portion of project costs from non-federal sources as a condition of receiving federal funds. The listing shows $0 for estimated total funding, award ceiling, and award floor, which is often a data-field artifact in continuation notices or system-generated records rather than a definitive statement that no funds are available; the core message is that this is a continuation action tied to prior awards rather than a newly budgeted open solicitation with published ranges.
Programmatically, the title and brief description indicate the continuation supports activities aligned with the global and national goals of poliomyelitis eradication and the Expanded Programme on Immunization (EPI), a framework widely used to improve routine immunization services and vaccine-preventable disease control. While the notice itself does not list specific workplan components, efforts under such initiatives typically focus on strengthening immunization delivery systems, improving vaccination coverage, supporting surveillance and outbreak response capacity, enhancing program management and data quality, and sustaining gains made toward polio eradication while reinforcing broader immunization infrastructure.
For assistance accessing the full announcement or related materials, the CDC points applicants to its Procurement and Grants Office (PGO). The contact information provided is a phone number (770-488-2700) and email (pgotim@cdc.gov), intended primarily for administrative or access issues rather than programmatic consultation.
Frequently Asked Questions (FAQs)
What is the official title of this funding opportunity?
The opportunity is titled "Poliomyelitis Eradication Initiative and Expanded Programme On Immunization".
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA GH13-130104CONT16.
Which federal agency is administering this opportunity?
This is administered by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is being used?
The funding instrument is a cooperative agreement.
What does it mean that this is a cooperative agreement (instead of a standard grant)?
A cooperative agreement generally indicates substantial involvement by the CDC in the supported work. Compared to a standard grant, this often means closer technical collaboration, more federal participation in planning or oversight, and active engagement in implementation and monitoring.
Is this an open competitive opportunity for new applicants?
No. This notice is explicitly described as continuation funding and is not an open competition.
Who is eligible to apply?
Eligibility is restricted to recipients that were already funded under the earlier related program announcement "GH13-1301 Poliomyelitis Eradication Initiative and Expanded Programme On Immunization".
The eligible applicant category says "Others." What does that mean here?
In this specific notice, "Others" does not mean the general public. The eligibility clarification indicates that "Others" refers to prior grantees funded under the original GH13-1301 announcement.
If an organization was not funded under the prior GH13-1301 award, can it apply now?
No. New applicants that were not part of the prior award cohort would not be able to compete for these continuation funds.
What is the CFDA number associated with this opportunity?
This opportunity is tied to CFDA 93.185.
What kinds of activities does CFDA 93.185 cover?
CFDA 93.185 covers immunization-related activities including research, demonstration, public information and education, training, and clinical skills improvement projects.
What is the broad activity area for this opportunity?
The opportunity is listed under the broad activity area of health.
When was this announcement posted/created?
The announcement was posted and created on August 1, 2015.
What was the application closing date?
The application closing date was September 25, 2015.
When was the opportunity archived?
The archive date was October 25, 2015.
How many awards were expected?
The notice indicates an expected 50 awards, suggesting an ongoing, multi-award effort rather than a single grant award.
Does this opportunity require cost sharing or matching funds?
No. The opportunity does not require cost sharing or matching.
How much funding is available (total funding, ceiling, or floor)?
The listing shows $0 for estimated total funding, award ceiling, and award floor. In continuation notices, this can be a system or data-field artifact rather than a definitive statement that no funds exist. The key point is that this is a continuation action tied to prior awards, not a newly competed solicitation with published funding ranges.
What program areas does this continuation support?
Based on the title and description, the continuation supports activities aligned with poliomyelitis eradication and the Expanded Programme on Immunization (EPI), which is widely used as a framework to improve routine immunization services and vaccine-preventable disease control.
Does the notice list specific required workplan components?
No. The notice does not provide specific workplan components.
What kinds of activities are typically associated with polio eradication and EPI work?
While the notice does not list detailed requirements, initiatives of this type commonly focus on strengthening immunization delivery systems, improving vaccination coverage, supporting surveillance and outbreak response capacity, enhancing program management and data quality, and sustaining gains toward polio eradication while reinforcing broader immunization infrastructure.
Who should be contacted for help accessing the full announcement or related materials?
The CDC directs applicants to its Procurement and Grants Office (PGO) for assistance accessing the full announcement or related materials.
What contact information is provided for the CDC Procurement and Grants Office (PGO)?
Phone: 770-488-2700
Email: pgotim@cdc.gov
Is the PGO contact intended for programmatic guidance or administrative/access issues?
The provided PGO contact is intended primarily for administrative or access issues rather than programmatic consultation.
Browse more opportunities from the same category: Health
Next opportunity: Suaahara II
Previous opportunity: Emerging Infections ProgramNational Center for Emerging and Zoonotic Infectious Diseases
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 130104CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 130104CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Enhancing Public Health Surveillance of Autism Spectrum Disorders and Other Developmental Disabilities through the Autism and Developmental Disabilities Monitoring (ADDM) Network Apply for CDC RFA DD15 150102CONT16 Funding Number: CDC RFA DD15 150102CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| National HIV Surveillance System (NHSS) Apply for CDC RFA PS13 13020401SUPP16 Funding Number: CDC RFA PS13 13020401SUPP16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $120,000 |
| AHRQ Grants for Health Services Research Dissertation Program (R36) Apply for PA 15 318 Funding Number: PA 15 318 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Tuskegee University Apology Commemoration Activities Apply for CDC RFA PS15 150402CONT16 Funding Number: CDC RFA PS15 150402CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NIMHD Transdisciplinary Collaborative Centers for Health Disparities Research on Chronic Disease Prevention (U54) Apply for RFA MD 15 014 Funding Number: RFA MD 15 014 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| U.S. India Collaborative Vision Research Program (R01) Apply for PAR 15 320 Funding Number: PAR 15 320 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Pilot Services Research Grants Not Involving Interventions (R34) Apply for PAR 15 323 Funding Number: PAR 15 323 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Special Diabetes Program for Indians Community Directed Program Apply for HHS 2016 IHS SDPI 0001 Funding Number: HHS 2016 IHS SDPI 0001 Agency: Indian Health Service Category: Health Funding Amount: $6,500,000 |
| Alzheimers Disease Core Centers (P30) Apply for RFA AG 16 018 Funding Number: RFA AG 16 018 Agency: National Institutes of Health Category: Health Funding Amount: $900,000 |
| Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Apply for RFA PS 16 001 Funding Number: RFA PS 16 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Building Genomic Sequencing Capacity in Kenya Apply for CDC RFA GH15 1636 Funding Number: CDC RFA GH15 1636 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Ethical, Legal and Policy Issues in HIV Research with Key Populations (R21) Apply for PAR 15 327 Funding Number: PAR 15 327 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Oral HIVacc Oral Mucosal Immunization Approaches for HIV Prevention (R01) Apply for RFA DE 16 006 Funding Number: RFA DE 16 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ethical, Legal and Policy Issues in HIV Research with Key Populations (R01) Apply for PAR 15 328 Funding Number: PAR 15 328 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| A National Coalition to Enhance STD/HIV Prevention through Promotion of a Holistic Approach to Health and Wellness Apply for CDC RFA PS11 111205CONT15 Funding Number: CDC RFA PS11 111205CONT15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Short term Measurements of Improved Physical and Molecular Resilience in Pre clinical Models (R01) Apply for RFA AG 16 006 Funding Number: RFA AG 16 006 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| USAID/GHANA PEOPLE FOR HEALTH Apply for RFA 641 15 000009 Funding Number: RFA 641 15 000009 Agency: Ghana USAID Accra Category: Health Funding Amount: $3,710,000 |
| Centers of Research Translation (P50) Apply for RFA AR 16 001 Funding Number: RFA AR 16 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Strengthening HIV/AIDS Continuum of Care Services Apply for RFA 641 15 000010 Funding Number: RFA 641 15 000010 Agency: Ghana USAID Accra Category: Health Funding Amount: $18,500,000 |
| Nonhuman Primate Reagent Resource (U24) Apply for RFA AI 15 038 Funding Number: RFA AI 15 038 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 130104CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.